Welcome to LookChem.com Sign In|Join Free
  • or
Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt, also known as Equilin 3-Sulfate Sodium Salt, is a metabolite of Equilin (E592800). It is an off-white solid with unique chemical properties that make it suitable for various applications in different industries.

16680-47-0

Post Buying Request

16680-47-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16680-47-0 Usage

Uses

Used in Pharmaceutical Industry:
Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt is used as a pharmaceutical compound for its potential therapeutic applications. As a metabolite of Equilin, it may have hormone-like effects and could be utilized in the development of drugs targeting hormonal imbalances or related conditions.
Used in Research and Development:
In the field of research and development, Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt serves as a valuable chemical intermediate. It can be used in the synthesis of other compounds or as a reference material for studying the properties and effects of Equilin and its metabolites.
Used in Analytical Chemistry:
Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt can be employed as a standard or reference material in analytical chemistry. It may be used to calibrate instruments, validate analytical methods, or as a control in experiments involving the analysis of steroidal compounds.
Used in Quality Control:
In the quality control of pharmaceutical products, Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt can be used as a reference substance to ensure the accuracy and reliability of testing methods and procedures.
Used in Environmental Testing:
Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt may also find applications in environmental testing, where it can be used as a tracer or reference material to monitor the presence of similar compounds in the environment, potentially indicating the presence of specific pollutants or contaminants.

Safety Profile

Confirmed carcinogen. When heated to decomposition it emits toxic fumes of SOx.

Check Digit Verification of cas no

The CAS Registry Mumber 16680-47-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,6,8 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 16680-47:
(7*1)+(6*6)+(5*6)+(4*8)+(3*0)+(2*4)+(1*7)=120
120 % 10 = 0
So 16680-47-0 is a valid CAS Registry Number.
InChI:InChI=1/C18H20O5S.Na/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;/h3-5,10,14,16H,2,6-9H2,1H3,(H,20,21,22);/q;+1/t14-,16+,18+;/m1./s1

16680-47-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name sodium,[(9S,13S,14S)-13-methyl-17-oxo-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfate

1.2 Other means of identification

Product number -
Other names Conjugen

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16680-47-0 SDS

16680-47-0Upstream product

16680-47-0Downstream Products

16680-47-0Relevant academic research and scientific papers

Process for isolating conjugated estrogens

-

Page/Page column 7-8, (2008/06/13)

The present invention relates to a process for extracting conjugated estrogens from pregnant mare urine. The present invention further relates to a process for obtaining a natural mixture of conjugated estrogens. The mixture of conjugated estrogens can be used to prepare products for estrogen replacement therapy or hormone replacement therapy. More specifically, the process for extracting conjugated estrogens from PMU comprises the steps of (a) contacting a mare urine material (MUM) with a resin to adsorb phenolic components, (b) contacting the phenolics-depleted MUM of step (a) with a resin to adsorb the stone and equilin, the major estrogen components, (c) containing the major estrogen-depleted MUM of step (b) with a resin to adsorb the minor estrogen components, (d) separately desorbing the major estrogen components and the minor estrogen components from the resins used in steps (b) and (c), and (e) separately treating the desorbed material form step (d) to obtain crystals of the major estrogen components and the minor estrogen components.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 16680-47-0